[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,882,315 Item 6: 0 Item 7: 6,569,315 Item 8: 0 Item 9: 6,569,315 Item 11: 14.104% Item 12: HC Cusip #64118U926 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,569,315 Item 8: 0 Item 9: 6,569,315 Item 11: 14.104%]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,882,315 Item 6: 0 Item 7: 6,569,315 Item 8: 0 Item 9: 6,569,315 Item 11: 14.104% Item 12: HC Cusip #64118U926 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,569,315 Item 8: 0 Item 9: 6,569,315 Item 11: 14.104%]
[EXECUTION VERSION CHINARD BLOODRPORATION 7% SENIORNVERTIBLE NOTE Original Principal Amount: US$50,000,000mpany Holder Principal and Issuancete and Note Notes Other Notes Registration Rightsreement FOR VALUE RECEIVED, Chinard Bloodrporation, an exemptedmpany with limited liabilityorporated in theyman Islands (the 1. Rank pari passu] [EXECUTION VERSION REGISTRATION RIGHTSREEMENT between CHINARD BLOODRPORATION and GOLDEN MEDITECHS LIMITEDted October 3, 2012 TABLE OFNTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THISREEMENT 5 Section 3 MANDATORY REGISTRATION 5 Section 4 DEMAND REGISTRATION RIGHTS 8 Section 5IDENTAL OR PIGGY-BACK REGISTRATION] [Chinard Bloodrporation Announcesmpletion of $50 Millionnvertible Note Financing with Golden Meditech HONG KONG, China, October 3, 2012 Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood banking operator in China, announced that it has successfullympleted the previously announced The board of directors of CCBC has appointed Mr. Yuen Kam, currently the Chairman and]
[EXECUTION VERSION CHINARD BLOODRPORATION 7% SENIORNVERTIBLE NOTE Original Principal Amount: US$50,000,000mpany Holder Principal and Issuancete and Note Notes Other Notes Registration Rightsreement FOR VALUE RECEIVED, Chinard Bloodrporation, an exemptedmpany with limited liabilityorporated in theyman Islands (the 1. Rank pari passu] [EXECUTION VERSION REGISTRATION RIGHTSREEMENT between CHINARD BLOODRPORATION and GOLDEN MEDITECHS LIMITEDted October 3, 2012 TABLE OFNTENTS Page Section 1 DEFINITIONS 1 Section 2 GENERAL; SECURITIES SUBJECT TO THISREEMENT 5 Section 3 MANDATORY REGISTRATION 5 Section 4 DEMAND REGISTRATION RIGHTS 8 Section 5IDENTAL OR PIGGY-BACK REGISTRATION] [Chinard Bloodrporation Announcesmpletion of $50 Millionnvertible Note Financing with Golden Meditech HONG KONG, China, October 3, 2012 Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood banking operator in China, announced that it has successfullympleted the previously announced The board of directors of CCBC has appointed Mr. Yuen Kam, currently the Chairman and]
[O2Micro Revises Third Quarter 2012 Financial Guidance 2 GEORGE TOWN, Grandyman, Oct. 3, 2012 (GLOBE NEWSWIRE) -- O The reduction in anticipated revenue for the third quarter is primarily the result of broad-based weakness in demand in thempany's end markets. 2 2 2 Sterling Du, Chairman and CEO of O]
